FDA.reportPublic FDA data

benzalkonium / tolnaftate

RxCUI
1000705
RxNorm name
benzalkonium / tolnaftate
Term type
MIN
Status
Active
Updated
2026-06-11 06:58:04

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tolnaftate10637
benzalkonium1378

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRbenzalkonium / tolnaftateNAMES
RxNorm Namebenzalkonium / tolnaftateNAMES
TTYMINATTRIBUTES
RxCUI1000705CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR02AAAntisepticsATC1-4benzalkonium
ATCD09AAMedicated dressings with antiinfectivesATC1-4benzalkonium
ATCD01AEOther antifungals for topical useATC1-4tolnaftate
ATCD08AJQuaternary ammonium compoundsATC1-4benzalkonium
MEDRTD001548Benzalkonium CompoundsCHEMhas_ingredientbenzalkonium chloride
MEDRTD001548Benzalkonium CompoundsCHEMhas_ingredientbenzalkonium
MEDRTD014047TolnaftateCHEMhas_ingredienttolnaftate
MEDRTD001424Bacterial InfectionsDISEASEmay_preventbenzalkonium chloride
MEDRTD001424Bacterial InfectionsDISEASEmay_preventbenzalkonium
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzalkonium chloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzalkonium
MEDRTD006967HypersensitivityDISEASEci_withtolnaftate
MEDRTD014009OnychomycosisDISEASEci_withtolnaftate
MEDRTD012536Scalp DermatosesDISEASEci_withtolnaftate
MEDRTD014008Tinea PedisDISEASEmay_treattolnaftate
MEDRTD014010Tinea VersicolorDISEASEmay_treattolnaftate
MEDRTN0000010265Squalene Monooxygenase InhibitorsMOAhas_moatolnaftate
MEDRTN0000008344Cellular Growth Phase ArrestPEhas_petolnaftate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYMIN
CODESRxCUI1000705
CODESSNOMEDCT420726007
NAMESRXNAV_STRbenzalkonium / tolnaftate
NAMESRxNorm Namebenzalkonium / tolnaftate
SOURCESSourceUS Edition of SNOMED_CT